K-Pharma announces listing on the Growth Market of the Tokyo Stock Exchange
Today, K-Pharma, a startup from Keio University School of Medicine, a portfolio company of Keio Innovation Initiative No. 2 Investment Limited Partnership managed by Keio Innovation Initiative (KII), was listed on the Growth Market of the Tokyo Stock Exchange.
For details, please see here.
https://www.kpharma.co.jp/news/press/20231017